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Abstract Cardiotypic development in embryonic stem cell-
derived embryoid bodies may be regulated by reactive oxygen
species (ROS). ROS were generated by a NADPH oxidase-like
enzyme which was transiently expressed during the time course of
embryoid body development. Incubation with either H2O2 or
menadione enhanced cardiomyogenesis, whereas the radical
scavengers trolox, pyrrolidinedithiocarbamate and N-acetylcys-
teine exerted inhibitory effects. The phosphatidylinositol 3-
kinase (PI-3-kinase) inhibitors LY294002 and wortmannin
abolished cardiac commitment and downregulated ROS in
embryoid bodies. Coadministration of LY294002 with proox-
idants resumed cardiomyocyte differentiation, indicating a role
for PI-3-kinase in the regulation of the intracellular redox
state. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Several transcription factors including Nkx2.5, GATA4/5/6
and MEF2C have been described to be involved in the tran-
scription of cardiac specifying genes [1,2]. Furthermore, car-
diomyocyte di¡erentiation is promoted by several growth fac-
tors and hormones, such as the ¢broblast growth factors
FGF-2, FGF-4, insulin, insulin-like growth factor I (IGF-I),
and activin [3,4]. However, the signal transduction pathways
that coordinate the action of growth factors and hormones on
plasma membrane-linked receptors with the transcription fac-
tors present in the cytoplasm and cell nucleus are virtually
unknown.
Recently, it has been demonstrated that phosphatidylinosi-
tol 3-kinase (PI-3-kinase) is involved in cardiac commitment,
since the speci¢c inhibitor LY294002 inhibited cardiomyogen-
esis in embryoid bodies cultivated from pluripotent murine
embryonic stem (ES) cells [5]. The molecular mechanism by
which PI-3-kinase promotes cardiomyocyte di¡erentiation
has, however, not yet been investigated.
The present study elucidates the signal transduction path-
way involving PI-3-kinase. It is demonstrated that reactive
oxygen species (ROS), which have been recently shown to
play a signi¢cant role in signal transduction pathways follow-
ing the binding of several growth factors to their cognate
receptors [6,7], are involved in cardiomyogenesis. Since it
has been demonstrated that PI-3-kinase activates the small
GTPase Rac [22], which is a component of the NADPH ox-
idase of neutrophils, it is assumed that PI-3-kinase may reg-
ulate ROS levels in embryoid bodies.
2. Materials and methods
2.1. Cell culture
The permanent ES cell line D3 [8], cultivated in undi¡erentiated
state on primary cultures of mouse embryonic ¢broblasts, was used
throughout the study. Cells were cultivated on feeder layers in Iscove’s
modi¢ed Eagle’s medium (Gibco BRL, Life Technologies, Germany)
supplemented with 15% fetal calf serum (Boehringer, Mannheim, Ger-
many), L-glutamine (2 mM) (Gibco BRL), L-mercaptoethanol (¢nal
concentration 5U1035 M) (Sigma, Deisenhofen, Germany), non-es-
sential amino acids (NAA; Gibco BRL; stock solution diluted 1:100),
100 IU/ml of penicillin, 0.1 mg/ml of streptomycin (Gibco BRL) in a
humidi¢ed atmosphere containing 5% CO2. The cell culture medium
was supplemented with leukemia inhibitory factor (10 Wg/ml) which
keeps ES cells in the undi¡erentiated state. At day 0 of di¡erentiation,
adherent cells were enzymatically dissociated using 0.2% trypsin and
0.05% EDTA in phosphate bu¡ered saline (PBS) and seeded at a
density of 1U107 cells/ml in 250 ml siliconized spinner £asks (Integra
Biosciences, Fernwald, Germany) containing 100 ml Iscove’s medium
supplemented with 20% fetal calf serum (Boehringer, Mannheim, Ger-
many), L-glutamine (2 mM) (Gibco BRL), L-mercaptoethanol (¢nal
concentration 5U1035 M) (Sigma, Deisenhofen, Germany), NAA
(Gibco BRL; stock solution diluted 1:100), 100 IU/ml of penicillin,
0.1 mg/ml of streptomycin (Gibco). After 24 h, 150 ml medium was
added for a ¢nal volume of 250 ml. The spinner £ask medium was
stirred at 20 rpm using a stirrer system (Integra Biosciences) and was
partly changed every day.
2.2. Incubation of embryoid bodies with inhibitors of PI-3-kinase,
prooxidants and free radical scavengers
The PI-3-kinase inhibitors wortmannin and LY294002 were pur-
chased from Sigma and Calbiochem (Bad Soden, Germany), respec-
tively. Trolox (water-soluble vitamin E) was purchased from Calbio-
chem, pyrrolidinedithiocarbamate (APDC), menadione, H2O2 and N-
acetylcysteine (NAC) were from Sigma. On day 3 of embryoid body
culture embryoid bodies were removed from the spinner £asks. Thirty
to forty embryoid bodies were added to each of 6-cm bacteriological
Petri dishes (Nunc, Wiesbaden, Germany), containing 6 ml cell culture
medium supplemented with either 1 WM wortmannin, 20 WM
LY294002, 10 nM H2O2, 20 WM menadione, 20 WM APDC, 30 WM
trolox, or 2 mM NAC. Cell culture medium supplemented with the
agents was completely exchanged every day. On day 7 of embryoid
body culture, the PI-3-kinase antagonists and radical scavengers were
removed and the embryoid bodies were plated to 24-well cell culture
dishes (Nunc). On day 2 after plating (7+2) beating embryoid bodies
were counted. The extension of the beating area of cardiomyocytes
was evaluated on day 7+5.
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2.3. Determination of the intracellular redox state
The intracellular redox state was investigated using the £uorescent
dye 2P7P-dichlorodihydro£uorescein diacetate (H2DCF-DA) (Molecu-
lar Probes, Eugene, OR, USA) which is a non-polar compound that is
converted into a non-£uorescent polar derivative (H2DCF) by cellular
esterases after incorporation into cells. The membrane-impermeable
H2DCF is rapidly oxidized to the highly £uorescent 2P,7P-dichloro-
£uorescein (DCF) in the presence of intracellular ROS [9]. Embryoid
bodies were incubated for 30 min with 10 WM H2DCF-DA (dissolved
in dimethylsulfoxide) in E1 bu¡er containing (in mM) NaCl 135, KCl
5.4, CaCl2 1.8, MgCl2 1, glucose 10, HEPES 10 (pH 7.4 at 37‡C).
After loading, the embryoid bodies were rinsed three times in E1
bu¡er and the DCF £uorescence was recorded by confocal laser scan-
ning microscopy. For £uorescence excitation the 488-nm line of the
argon ion laser was used. Fluorescence emission recording was per-
formed with a longpass LP515 nm ¢lter set. In the experiments where
the time course of H2DCF oxidation was monitored, embryoid bodies
immersed in E1 bu¡er were incubated with 10 WM H2DCF-DA and
the time-dependent increase of DCF £uorescence was monitored with-
out preincubation. Full frame images (512U512 pixels) were taken
every 120 or 180 s. DCF £uorescence was evaluated in 5000 Wm2
regions of interest (ROIs) in the center of embryoid bodies. Data
are presented in arbitrary units as percentage of £uorescence variation
F with respect to the resting level F0.
2.4. Immunohistochemistry
Immunohistochemistry was performed with whole-mount embryoid
bodies. Embryoid bodies either in suspension culture or plated on
coverslips were washed three times in PBS and subsequently ¢xed in
ice-cold 7:3 methanol/acetone for 60 min. After washing for three
times with PBS (pH 7.4) containing 0.1% Triton X-100 (PBST) em-
bryoid bodies were incubated for 1 h in PBS containing 10% milk
powder to block against unspeci¢c binding. Incubation with primary
antibodies was performed for 1 h in PBS containing 10% milk pow-
der. After incubation with the primary antibody embryoid bodies
were washed three times with PBST and staining with secondary anti-
bodies was performed in PBS containing 10% milk powder. The pri-
mary antibodies used were: monoclonal anti-K-actinin (sarcomeric),
clone number EA-53 (Sigma, Deisenhofen, Germany) used in a con-
centration of 10 Wg/ml and monoclonal anti-p67phox (Dianova, Ham-
burg, Germany) used at a concentration of 12.5 Wg/ml. As secondary
antibody a Cy51-conjugated rabbit anti-mouse IgG (H+L) (Dianova,
Germany) was used in a 1:150 dilution. Excitation was performed
using the 633-nm band of a He^Ne laser of the confocal setup. Emis-
sion was recorded using a longpass LP655 nm ¢lter set. For the semi-
quantitative evaluation of p67phox protein, £uorescence was recorded
in 3000 Wm2 ROIs at the periphery of embryoid bodies. The thickness
of the optical section (full width half maximum) was adjusted to 20
Wm.
2.5. Statistical analysis
Data are given as mean values þ S.E.M. with n denoting the number
of experiments performed with di¡erent embryoid body cultures. In
each experiment at least 30 embryoid bodies were examined unless
otherwise indicated. Student’s t-test for unpaired data was applied as
appropriate. A value of P6 0.05 was considered signi¢cant.
3. Results
3.1. Endogenous generation of ROS in embryoid bodies
To investigate whether ROS are involved in signal trans-
duction pathways resulting in cardiac commitment, the intra-
cellular generation of ROS was investigated in embryoid
bodies using the £uorescent ROS indicator H2DCF-DA. As
demonstrated in Fig. 1 embryoid bodies endogenously gener-
ated ROS in signi¢cant amounts. Maximum ROS generation
was observed in 2^3-day-old embryoid bodies. A signi¢cant
decay in the oxidation kinetics of H2DCF with increased cul-
tivation time was observed in 4-, 6- and 11-day-old embryoid
bodies (n = 3 for each experimental condition).
The intracellular level of ROS in cells is determined either
by the activity of NADPH oxidase-like enzymes and/or the
mitochondrial respiratory chain which generates the superox-
ide anion which is subsequently dismutated to H2O2 by cata-
lase [10]. Hence the amount of ROS generated during embry-
oid body development may be limited by the expression of a
NADPH oxidase-like enzyme. To evaluate the role of a
NADPH oxidase-like enzyme in the endogenous ROS gener-
ation in embryoid bodies, 2^3-day-old embryoid bodies were
incubated with 10 WM diphenyleneiodonium chloride (DPI),
which inhibits NADPH oxidase activity [11]. Subsequently
DCFH oxidation was monitored. We observed that under
these experimental conditions intracellular ROS generation
was signi¢cantly inhibited and was not signi¢cantly di¡erent
from the ROS generation observed in undi¡erentiated ES cells
cultivated on feeder cells (n = 3 for each experimental condi-
tion) (see Fig. 1).
A decrease of ROS generation with prolonged cell culture
times of embryoid bodies may be correlated to a decay in the
expression of the NADPH oxidase complex. Therefore, 2^3-,
6- and 12-day-old embryoid bodies were investigated with
respect to the expression of p67phox which is a subunit of
the NADPH oxidase involved in the respiratory burst of neu-
trophils. It was observed that the decay in ROS generation
during the development of embryoid bodies correlated well
with a decrease in p67phox expression with the highest expres-
sion in 2^3-day-old embryoid bodies and a gradual decline
within 11^12 days of cell culture (n = 3) (Fig. 2).
3.2. E¡ects of external H2O2 and menadione on cardiomyocyte
di¡erentiation
If ROS were involved in the signal transduction process
leading to cardiomyocyte di¡erentiation, an increase of intra-
cellular ROS should promote cardiomyogenesis, whereas
Fig. 1. Endogenous generation of ROS in ES cells and embryoid
bodies during di¡erent developmental stages. Time course of
H2DCF oxidation in undi¡erentiated ES cells, in 2^3-, 4-, 6-, and
11-day-old embryoid bodies and in 2^3-day-old embryoid bodies in
the presence of 10 WM DPI. Embryoid bodies were incubated with
20 WM H2DCF-DA and the oxidation of non-£uorescent H2DCF
to £uorescent DCF was monitored. About 10 embryoid bodies in
each of three independent experiments were used for the determina-
tion of each data point.
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scavengers of ROS exert inhibitory e¡ects. Therefore, in a ¢rst
set of experiments, 3-day-old embryoid bodies were incubated
with either 10 nM H2O2 or 20 WM menadione which is known
to generate H2O2 [12]. As shown in Fig. 3A incubation with
H2O2 as well as menadione signi¢cantly increased the percent-
age of embryoid bodies containing beating areas of cardio-
myocytes at day 7+2 (n = 3 for each experimental condition).
Concomitant with the increase of the number of beating em-
bryoid bodies the size of the beating area (evaluated on day
7+5) was signi¢cantly augmented in embryoid bodies treated
with ROS-generating agents (n = 3 for each experimental con-
dition) (Fig. 3B). In a second set of experiments embryoid
bodies were incubated with the free radical scavengers trolox
(30 WM), NAC (2 mM) as well as APDC (20 WM) which is
also known to inhibit apoptosis [13] and oxidize ferrous ions
[14]. Following incubation with antioxidants the number of
beating embryoid bodies was counted on day 7+2 after plat-
ing. Treatment of embryoid bodies with scavengers of free
radicals resulted in a signi¢cant decrease in the number of
beating embryoid bodies by approximately 50%, which under-
scores our assumption of an involvement of ROS in cardio-
myogenesis (Fig. 4) (n = 3 for each experimental condition).
Fig. 2. Expression of a NADPH oxidase-like enzyme during embry-
oid body development. Top: Immunostaining of representative em-
bryoid bodies with an antibody directed against the p67phox subunit
of the neutrophil NADPH oxidase (bar = 50 Wm). a: Control (only
secondary antibody). b: Two-day-old embryoid body. c: Five-day-
old embryoid body. d: Twelve-day-old embryoid body (bar = 50
Wm). Bottom: Quantitative immunohistochemistry of p67phox in em-
bryoid bodies of di¡erent developmental stages. Data show the
means þ S.E.M. of at least 30 embryoid bodies evaluated in one of
three experiments with comparable results. *P6 0.05, signi¢cantly
di¡erent from the untreated control.
Fig. 3. E¡ects of the prooxidants H2O2 (10 nM) and menadione (20
WM) on the number of embryoid bodies di¡erentiating foci of spon-
taneously contracting cardiomyocytes (A) and on the area of the
beating foci (B). Note that prooxidants signi¢cantly enhanced cardi-
omyocyte di¡erentiation in embryoid bodies. *P6 0.05, signi¢cantly
di¡erent from the untreated control.
Fig. 4. E¡ects of the free radical scavengers trolox (30 WM), APDC
(20 WM), and NAC (2 mM) on cardiomyocyte di¡erentiation. Em-
bryoid bodies were treated from day 3 to day 7 of cell culture with
the compounds. Subsequently they were plated in the absence of the
compounds and the number of spontaneously contracting embryoid
bodies was counted 2 days later (7+2). *P6 0.05, signi¢cantly di¡er-
ent from the untreated control.
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3.3. Role of PI-3-kinase in cardiomyogenesis
In a recent study it was demonstrated that PI-3-kinase is
involved in cardiac cell di¡erentiation since incubation of em-
bryoid bodies with the PI-3-kinase inhibitor LY294002 signi¢-
cantly inhibited cardiac commitment [5]. However, the mech-
anism of action of PI-3-kinase was not investigated. It has
been previously shown that superoxide generation by
NADPH oxidase is inhibited by antagonists of PI-3-kinase
[15], which may indicate that the intracellular redox state is
regulated by this enzyme. To evaluate whether the involve-
ment of PI-3-kinase in cardiomyogenesis of ES cells is related
to its modulatory e¡ect on the generation of ROS, 3-day-old
embryoid bodies were preincubated for 24 h either with 20
WM LY294002 or with 1 WM wortmannin which are both
speci¢c inhibitors of PI-3-kinase. Subsequently the intracellu-
lar generation of ROS was evaluated by recording DCF £uo-
rescence using confocal laser scanning microscopy. Our data
demonstrate that LY294002 (n = 4) as well as wortmannin
(n = 6) signi¢cantly reduced the ROS levels present in embry-
oid bodies as compared to the untreated control (set at 100%)
(Fig. 5A). This clearly indicates that PI-3-kinase is involved in
the regulation of the intracellular redox state in embryoid
bodies.
The data presented so far demonstrate that treatment of
embryoid bodies with PI-3-kinase inhibitors resulted in a re-
duction of ROS in embryoid bodies concomitant with a de-
crease of the number of beating foci and a reduction of the
size of the area of cardiomyocytes. Hence raising the intra-
cellular ROS levels in the presence of inhibitors of PI-3-kinase
should restore cardiomyocyte di¡erentiation. We therefore in-
cubated embryoid bodies either with LY294002 alone or in
combination with the prooxidants menadione (20 WM) or
H2O2 (10 nM). On day 7+2 after plating the development
of beating area was investigated. The extension of beating
areas was analyzed by immunohistochemistry on day 7+5.
LY294002 signi¢cantly decreased the number of beating em-
bryoid bodies (Fig. 5B) and reduced the extension of the beat-
ing area (n = 3 for each experimental condition) (Fig. 5C).
Upon coadministration of LY294002 with prooxidants the
number of beating embryoid bodies as well as the extension
of the beating area was restored (n = 3 for each experimental
condition) (see Figs. 5C and 6). A comparable e¡ect on the
number of beating embryoid bodies was achieved following
incubation of embryoid bodies with 1 WM wortmannin (data
not shown). Hence our data demonstrate that the role of PI-3-
kinase on cardiomyocyte di¡erentiation is related to the reg-
ulation of the intracellular redox state.
4. Discussion
Although a number of transcription factors have been de-
scribed to be essential for the commitment of the cardiac cell
lineage, the involved signal transduction pathways are not
well de¢ned. It is well documented that angiotensin II [16]
as well as IGF-I [17], b-FGF [18] and interleukin-1L [19] raise
intracellular ROS in cells, which points towards the direction
that hormones and cytokines involved in cardiac cell di¡er-
entiation use the common route of ROS generation.
In embryoid bodies ROS were generated predominantly via
a NADPH oxidase-like enzyme, since positive immunostain-
ing was observed with an antibody raised against the p67phox
unit of the neutrophil NADPH oxidase and ROS generation
was signi¢cantly inhibited after preincubation of embryoid
bodies with DPI which is an inhibitor of £avoproteins includ-
ing the superoxide-generating NADPH oxidase [11]. Experi-
mental evidence for the involvement of an NADPH oxidase-
like enzyme and the intracellular redox state in cardiomyo-
genesis has not yet been provided. Recent studies suggest a
role for PI-3-kinase in signaling pathways which induce car-
diomyogenesis. It was shown that cardiomyogenesis in embry-
oid bodies was signi¢cantly inhibited in the presence of
LY294002 [5] which is a speci¢c inhibitor of PI-3-kinase. Fur-
thermore, wortmannin, another PI-3-kinase antagonist, inhib-
ited the chamber growth and maturation observed for the
combined treatment of murine embryos with neuregulin 1
and IGF-I, suggesting that these growth factors act through
convergent activation of the PI-3-kinase [20]. In the latter
study comparable e¡ects were observed for the adenoviral
Fig. 5. E¡ect of the PI-3-kinase inhibitors LY294002 (20 WM) and
wortmannin (1 WM) on intracellular ROS levels and cardiomyocyte
di¡erentiation. A: ROS levels in embryoid bodies following incuba-
tion of 3^4-day-old embryoid bodies for 24 h with PI-3-kinase in-
hibitors. Note that PI-3-kinase antagonists signi¢cantly reduced the
ROS levels in embryoid bodies. B, C: E¡ects of the PI-3-kinase in-
hibitor LY294002 on the number of embryoid bodies di¡erentiating
foci of contracting cardiomyocytes (evaluated on day 7+2) (B) and
on the area of the beating foci (evaluated on day 7+5) (C). Note
that upon coadministration of LY294002 with the prooxidants
H2O2 (10 nM) and menadione (20 WM) cardiomyocyte di¡erentia-
tion was restored to the control level, which indicates that PI-3-ki-
nase is involved in the regulation of ROS levels in embryoid bodies.
*P6 0.05, signi¢cantly di¡erent from the untreated control.
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delivery of dominant negative Rac1, which acts downstream
of PI-3-kinase. Rac1 and Rac2 interact with the NADPH
oxidase subunit p67phox thereby regulating enzyme activity
and superoxide generation [21]. The activation of Rac2 has
been recently shown to be inhibited by wortmannin and
LY294002 [22].
In the present study cardiomyogenesis was enhanced upon
treatment of embryoid bodies with prooxidants. On the other
hand scavengers of ROS inhibited cardiomyocyte di¡erentia-
tion. These data clearly indicate that cardiac cell di¡erentia-
tion in embryoid bodies is critically dependent on the intra-
cellular redox state and substantiate our previous experiments
which demonstrated that electrical ¢elds enhanced cardiomyo-
cyte di¡erentiation in embryoid bodies via an elevation of the
intracellular redox state [23].
The data of the present study furthermore demonstrate that
both wortmannin and LY294002 signi¢cantly reduced ROS
levels in embryoid bodies which corroborates the results of
others which have demonstrated that inhibitors of PI-3-kinase
inhibit the respiratory burst in phagocytic cells [24^27]. The
role of PI-3-kinase in cardiomyocyte di¡erentiation of ES cells
is apparently related to the regulation of intracellular ROS
levels since in our experiments coadministration of the PI-3-
kinase inhibitor LY294002 with prooxidants restored cardio-
myocyte di¡erentiation to the control level.
To our knowledge, our study for the ¢rst time indicates that
cardiomyogenesis in embryoid bodies is regulated by the in-
tracellular redox state. It has been previously shown that skel-
etal muscle di¡erentiation induced by IGFs involves nuclear
factor UB and nitric oxide synthase activities downstream of
PI-3-kinase [28]. Since both cardiac cells and skeletal muscle
cells originate from the mesodermal cell lineage, common sig-
naling pathways may be involved in cardiomyogenesis and
skeletal muscle di¡erentiation.
References
[1] Mohun, T. and Sparrow, D. (1997) Curr. Opin. Genet. Dev. 7,
628^633.
[2] Charron, F. and Nemer, M. (1999) Semin. Cell Dev. Biol. 10, 85^
91.
[3] Yatskievych, T.A., Ladd, A.N. and Antin, P.B. (1997) Develop-
ment 124, 2561^2570.
[4] Antin, P.B., Yatskievych, T., Dominguez, J.L. and Chie⁄, P.
(1996) J. Cell Physiol. 168, 42^50.
[5] Klinz, F., Bloch, W., Addicks, K. and Hescheler, J. (1999) Exp.
Cell Res. 247, 79^83.
[6] Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon,
E.R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont,
P.J. (1997) Science 275, 1649^1652.
[7] Clement, M.V. and Pervaiz, S. (1999) Free Radical Res. 30, 247^
252.
[8] Doetschman, T.C., Eistetter, H., Katz, M., Schmidt, W. and
Kemler, R. (1985) J. Embryol. Exp. Morphol. 87, 27^45.
[9] Frenkel, K. and Gleichauf, C. (1991) Free Radical Res. Com-
mun. 12/13 (Pt. 2), 783^794.
[10] Bergendi, L., Benes, L., Durackova, Z. and Ferencik, M. (1999)
Life Sci. 65, 1865^1874.
[11] Doussiere, J., Gaillard, J. and Vignais, P.V. (1999) Biochemistry
38, 3694^3703.
[12] Suzuki, Y. and Ono, Y. (1999) Biochem. Biophys. Res. Commun.
255, 262^267.
Fig. 6. Reversal of LY294002-mediated inhibition of cardiomyocyte di¡erentiation in embryoid bodies by the prooxidants H2O2 (10 nM) and
menadione (20 WM). Embryoid bodies were treated from day 3 to day 7 with the compounds and were subsequently plated. They were stained
for sarcomeric K-actinin on day 7+5. Shown are representative foci of cardiac cells. A: Control. B: LY294002. C: H2O2+LY294002. D: Mena-
dione+LY294002. The bar represents 150 Wm.
FEBS 23868 30-6-00 Cyaan Magenta Geel Zwart
H. Sauer et al./FEBS Letters 476 (2000) 218^223222
[13] Nobel, C.S., Burgess, D.H., Zhivotovsky, B., Burkitt, M.J., Or-
renius, S. and Slater, A.F. (1997) Chem. Res. Toxicol. 10, 636^
643.
[14] Liu, J., Shigenaga, M.K., Yan, L.J., Mori, A. and Ames, B.N.
(1996) Free Radical Res. 24, 461^472.
[15] Marumo, T., Schini-Kerth, V.B., Fisslthaler, B. and Busse, R.
(1997) Circulation 96, 2361^2367.
[16] Ushio-Fukai, M., Alexander, R.W., Akers, M., Yin, Q., Fujio,
Y., Walsh, K. and Griendling, K.K. (1999) J. Biol. Chem. 274,
22699^22704.
[17] Krieger-Brauer, H.I. and Kather, H. (1995) Biochem. J. 307,
549^556.
[18] Lo, Y.Y. and Cruz, T.F. (1995) J. Biol. Chem. 270, 11727^
11730.
[19] Bonizzi, G., Piette, J., Merville, M.P. and Bours, V. (2000) Bio-
chem. Pharmacol. 59, 7^11.
[20] Hertig, C.M., Kubalak, S.W., Wang, Y. and Chien, K.R. (1999)
J. Biol. Chem. 274, 37362^37369.
[21] Dorseuil, O., Reibel, L., Bokoch, G.M., Camonis, J. and Gacon,
G. (1996) J. Biol. Chem. 271, 83^88.
[22] Akasaki, T., Koga, H. and Sumimoto, H. (1999) J. Biol. Chem.
274, 18055^18059.
[23] Sauer, H., Rahimi, G., Hescheler, J. and Wartenberg, M. (1999)
J. Cell Biochem. 75, 710^723.
[24] Lynch, O.T., Giembycz, M.A., Barnes, P.J., Hellewell, P.G. and
Lindsay, M.A. (1999) Br. J. Pharmacol. 128, 1149^1158.
[25] Wang, D., Youngson, C., Wong, V., Yeger, H., Dinauer, M.C.,
Vega-Saenz Miera, E., Rudy, B. and Cutz, E. (1996) Proc. Natl.
Acad. Sci. USA 93, 13182^13187.
[26] Dang, P.M., Dewas, C., Gaudry, M., Fay, M., Pedruzzi, E.,
Gougerot-Pocidalo, M.A. and El Benna, J. (1999) J. Biol.
Chem. 274, 20704^20708.
[27] Thelen, M. and Didichenko, S.A. (1997) Ann. NY Acad. Sci.
832, 368^382.
[28] Kaliman, P., Canicio, J., Testar, X., Palacin, M. and Zorzano, A.
(1999) J. Biol. Chem. 274, 17437^17444.
FEBS 23868 30-6-00 Cyaan Magenta Geel Zwart
H. Sauer et al./FEBS Letters 476 (2000) 218^223 223
